General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Swedish Orphan Biovitrum AB (SOBI) Pharmaceuticals(SIGNIFICANT), Medtronic(SIGNIFICANT), Kiniksa Pharmaceuticals(MODEST), Cardiol Therapeutics(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Ventyx Biosciences(NONE)

View Full Disclosure